Sign inJoin waitlistJoin the waitlist

Laura Bukavina

Translational Science Lead in GU Oncology · Cleveland Clinic Lerner College of Medicine

Credentials: · · · · ·

History

Case Western Reserve University
Present
Cleveland Clinic, School of Medicine
Present

Drexel University
2024
Johns Hopkins University School of Medicine
2023–2024
Fox Chase Cancer Center
2022–2023
Urology
Case Western Reserve University/University Hospitals Cleveland Medical Center
2014–2016
Internal Medicine
Summa Health System
2013–2014
Johns Hopkins School of Medicine
Northeast Ohio Medical University
2009–2013
Cleveland State University
2007

Research

Epidemiology of Renal Cell Carcinoma: 2022 Update
Systematic review or meta-analysis · European Urology · 2022 · First of 16 authors · 648 citations
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors
Systematic review or meta-analysis · European Urology · 2023 · 435 citations
Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors
European Urology · 2025 · 75 citations

Kirtishri Mishra
48 papers · 45 as a resident
Lee Ponsky
37 papers
Adam Calaway
34 papers · 1 as a fellow
Alexander Kutikov
30 papers
AM
Amr Mahran
24 papers · 11 as a resident
Megan Prunty
24 papers · 23 as a resident
Andres Correa
18 papers
Christopher Weight
18 papers
Ilaha Isali
18 papers · 5 as a resident
Philip Abbosh
18 papers
Robert Uzzo
14 papers
Betty Wang
12 papers

Clinical trials

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Site PI · Recruiting · Phase 2
CG Oncology, Inc.
2024–2027
ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer
Site PI · Available
ImmunityBio, Inc.